Christian Mark
School of Science and Technology, Nottingham Trent University, Clifton, Nottingham, NG11 8NS, UK.
Exp Physiol. 2020 Aug;105(8):1201-1205. doi: 10.1113/EP087877. Epub 2020 Mar 29.
What is the topic of this review? Activation of brown adipose tissue with G protein-coupled receptors as key druggable targets as a strategy to increase energy consumption and reduce fat mass. What advances does it highlight? GPR120 is a fatty acid receptor highly expressed in brown adipose tissue. Its activation by selective ligands increases brown adipose tissue activity. This is mediated by changes in mitochondrial dynamics resulting in increased O consumption leading to enhanced nutrient uptake and a reduction in fat mass.
The identification of druggable targets to stimulate brown adipose tissue (BAT) is a strategy to combat obesity due to this highly metabolically active tissue utilising thermogenesis to burn fat. Upon cold exposure BAT is activated by the sympathetic nervous system via β -adrenergic receptors. Determination of additional receptors expressed by brown, white and brite (brown-in-white) fat can lead to new pharmacological treatments to activate BAT. GPR120 is a G protein-coupled fatty acid receptor that is highly expressed in BAT and further increases in response to cold. Activation of this receptor with the selective agonist TUG-891 acutely increases fat oxidation and reduces fat mass in mice. The effects are coincident with increased BAT activity and enhanced nutrient uptake. TUG-891 stimulation of brown adipocytes induces intracellular Ca release which results in elevated O consumption as well as mitochondrial depolarisation and fission. Thus, activation of GPR120 in BAT with ligands such as TUG-891 is a promising strategy to increase fat consumption.
本综述的主题是什么?以G蛋白偶联受体作为关键可成药靶点激活棕色脂肪组织,作为增加能量消耗和减少脂肪量的一种策略。它突出了哪些进展?GPR120是一种在棕色脂肪组织中高度表达的脂肪酸受体。其被选择性配体激活可增加棕色脂肪组织的活性。这是由线粒体动力学变化介导的,导致耗氧量增加,从而增强营养物质摄取并减少脂肪量。
识别可刺激棕色脂肪组织(BAT)的可成药靶点是对抗肥胖的一种策略,因为这种高代谢活性组织利用产热来燃烧脂肪。在寒冷暴露时,BAT通过β-肾上腺素能受体被交感神经系统激活。确定棕色、白色和米色(白中带棕)脂肪表达的其他受体可带来激活BAT的新的药物治疗方法。GPR120是一种G蛋白偶联脂肪酸受体,在BAT中高度表达,并在寒冷刺激下进一步增加。用选择性激动剂TUG-891激活该受体可急性增加小鼠的脂肪氧化并减少脂肪量。这些作用与BAT活性增加和营养物质摄取增强同时发生。TUG-891刺激棕色脂肪细胞可诱导细胞内钙释放,从而导致耗氧量增加以及线粒体去极化和裂变。因此,用TUG-891等配体激活BAT中的GPR120是增加脂肪消耗的一种有前景的策略。